{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T09:47:35Z","timestamp":1790070455480,"version":"4.0.1"},"reference-count":95,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"published-print":{"date-parts":[[2012,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>The bidirectional interation between pancreatic cancer (PanCa) and diabetes has been confirmed by epidemiological studies, which provide evidence-based medical support for further research into the mechanisms involved in the interaction. We reviewed the literature regarding the role of diabetes in the generation and progression of PanCa and the mechanism by which PanCa induces diabetes for its malignant progression. The effect of antidiabetic drugs on the occurrence and prognosis of PanCa was also reviewed. Diabetes may directly promote the progression of PanCa by pancreatic duct enlargement and hypertension, as well as by enabling an increased tumor volume. Hyperinsulinemia, insulin resistance, cytokines, hyperglycemia and genotype change are also important factors in the progression of PanCa with diabetes. Hyperglycemia may be the first clinical manifestation and is helpful in the early diagnosis of PanCa. Furthermore, antidiabetic drugs can have different effects on the occurrence and prognosis of PanCa. The bidirectional interation between PanCa and diabetes is involved in the occurrence, proliferation, invasion, metastasis and prognosis of PanCa with diabetes. The discovery of biomarkers for the early diagnosis of PanCa, as well as the novel usage of metformin for its antitumor effects and determining the potential mechanisms of these effects, may be the next direction for PanCa research and treatment.<\/jats:p>","DOI":"10.1186\/1477-7819-10-171","type":"journal-article","created":{"date-parts":[[2012,8,24]],"date-time":"2012-08-24T18:15:34Z","timestamp":1345832134000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["The bidirectional interation between pancreatic cancer and diabetes"],"prefix":"10.1186","volume":"10","author":[{"given":"Junhui","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingyong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,8,24]]},"reference":[{"key":"1092_CR1","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1056\/NEJMra0901557","volume":"362","author":"M Hidalgo","year":"2010","unstructured":"Hidalgo M: Pancreatic cancer. N Engl J Med. 2010, 362: 1605-1617.","journal-title":"Pancreatic cancer. N Engl J Med"},{"key":"1092_CR2","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1002\/cncr.27514","volume":"118","author":"C Eheman","year":"2012","unstructured":"Eheman C, Henley SJ, Ballard-Barbash R, Jacobs EJ, Schymura MJ, Noone AM, Pan L, Anderson RN, Fulton JE, Kohler BA, Jemal A, Ward E, Plescia M, Ries LA, Edwards BK: Annual Report to the Nation on the status of cancer, 1975-2008, featuring cancers associated with excess weight and lack of sufficient physical activity. Cancer. 2012, 118: 2338-2366. 10.1002\/cncr.27514.","journal-title":"Cancer"},{"key":"1092_CR3","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1055\/s-0029-1243193","volume":"118","author":"VA Grote","year":"2010","unstructured":"Grote VA, Becker S, Kaaks R: Diabetes mellitus type 2 - an independent risk factor for cancer?. Exp Clin Endocrinol Diabetes. 2010, 118: 4-8. 10.1055\/s-0029-1243193.","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"1092_CR4","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1038\/sj.bjc.6602619","volume":"92","author":"R Huxley","year":"2005","unstructured":"Huxley R, Ansary-Moghaddam A, Berrington De-Gonz\u00c3\u00a1lez A, Barzi F, Woodward M: Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies. Br J Cancer. 2005, 92: 2076-2083. 10.1038\/sj.bjc.6602619.","journal-title":"Br J Cancer"},{"key":"1092_CR5","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s10552-010-9686-3","volume":"22","author":"D Li","year":"2011","unstructured":"Li D, Tang H, Hassan MM, Holly EA, Bracci PM, Silverman DT: Diabetes and risk of pancreatic cancer: a pooled analysis of three large case-control studies. Cancer Causes Control. 2011, 22: 189-197. 10.1007\/s10552-010-9686-3.","journal-title":"Cancer Causes Control"},{"key":"1092_CR6","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1038\/sj.bjc.6605240","volume":"101","author":"AA Ogunleye","year":"2009","unstructured":"Ogunleye AA, Ogston SA, Morris AD, Evans JM: A cohort study of the risk of cancer associated with type 2 diabetes. Br J Cancer. 2009, 101: 1199-1201. 10.1038\/sj.bjc.6605240.","journal-title":"Br J Cancer"},{"key":"1092_CR7","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1097\/MPA.0b013e318209e05d","volume":"40","author":"JT Magruder","year":"2011","unstructured":"Magruder JT, Elahi D, Andersen DK: Diabetes and pancreatic cancer: chicken or egg?. Pancreas. 2011, 40: 339-351. 10.1097\/MPA.0b013e318209e05d.","journal-title":"Pancreas"},{"key":"1092_CR8","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1007\/s00125-011-2242-1","volume":"54","author":"JA Johnson","year":"2011","unstructured":"Johnson JA, Bowker SL, Richardson K, Marra CA: Time-varying incidence of cancer after the onset of type 2 diabetes: evidence of potential detection bias. Diabetologia. 2011, 54: 2263-2271. 10.1007\/s00125-011-2242-1.","journal-title":"Diabetologia"},{"key":"1092_CR9","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/1741-7015-5-25","volume":"5","author":"MC Perrin","year":"2007","unstructured":"Perrin MC, Terry MB, Kleinhaus K, Deutsch L, Yanetz R, Tiram E, Calderon R, Friedlander Y, Paltiel O, Harlap S: Gestational diabetes as a risk factor for pancreatic cancer: a prospective cohort study. BMC Med. 2007, 5: 25-31. 10.1186\/1741-7015-5-25.","journal-title":"BMC Med"},{"key":"1092_CR10","volume-title":"Pancreas","author":"CH Tseng","year":"2012","unstructured":"Tseng CH: New-onset diabetes with a history of dyslipidemia predicts pancreatic cancer. Pancreas. 2012, Jun. [Epub ahead of print]"},{"key":"1092_CR11","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1002\/cncr.10493","volume":"94","author":"Y Ogawa","year":"2002","unstructured":"Ogawa Y, Tanaka M, Inoue K, Yamaguchi K, Chijiiwa K, Mizumoto K, Tsutsu N, Nakamura Y: A prospective pancreatographic study of the prevalence of pancreatic carcinoma in patients with diabetes mellitus. Cancer. 2002, 94: 2344-2349. 10.1002\/cncr.10493.","journal-title":"Cancer"},{"key":"1092_CR12","doi-asserted-by":"publisher","first-page":"167","DOI":"10.4166\/kjg.2009.54.3.167","volume":"54","author":"SG Hong","year":"2009","unstructured":"Hong SG, Jung SJ, Joo MK, Lee BJ, Yeon JE, Park JJ, Byun KS, Bak YT: Prevalence of pancreatic cancer in diabetics and clinical characteristics of diabetes-associated with pancreatic cancer-comparison between diabetes with and without pancreatic cancer. Korean J Gastroenterol. 2009, 54: 167-173. 10.4166\/kjg.2009.54.3.167.","journal-title":"Korean J Gastroenterol"},{"key":"1092_CR13","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.gastro.2005.05.007","volume":"129","author":"ST Chari","year":"2005","unstructured":"Chari ST, Leibson CL, Rabe KG, Ransom J, de Andrade M, Petersen GM: Probability of pancreatic cancer following diabetes: a population-based study. Gastroenterology. 2005, 129: 504-511.","journal-title":"Gastroenterology"},{"key":"1092_CR14","doi-asserted-by":"publisher","first-page":"5274","DOI":"10.3748\/wjg.15.5274","volume":"15","author":"MM Jamal","year":"2009","unstructured":"Jamal MM, Yoon EJ, Vega KJ, Hashemzadeh M, Chang KJ: Diabetes mellitus as a risk factor for gastrointestinal cancer among American veterans. World J Gastroenterol. 2009, 15: 5274-5278. 10.3748\/wjg.15.5274.","journal-title":"World J Gastroenterol"},{"key":"1092_CR15","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/sj.bjc.6603571","volume":"96","author":"RJ Stevens","year":"2007","unstructured":"Stevens RJ, Roddam AW, Beral V: Pancreatic cancer in type 1 and young-onset diabetes: systematic review and meta-analysis. Br J Cancer. 2007, 96: 507-509. 10.1038\/sj.bjc.6603571.","journal-title":"Br J Cancer"},{"key":"1092_CR16","doi-asserted-by":"crossref","first-page":"257","DOI":"10.4318\/tjg.2009.0022","volume":"20","author":"M Saru\u00c3\u00a7","year":"2009","unstructured":"Saru\u00c3\u00a7 M, Karaarslan M, Rasa K, Saygili O, Ince U, Baysal C, Pour PM, Cakmak\u00c3\u00a7i M, T\u00c3\u00b6z\u00c3\u00bcn N: Pancreatic cancer and glucose metabolism. Turk J Gastroenterol. 2009, 20: 257-260.","journal-title":"Turk J Gastroenterol"},{"key":"1092_CR17","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1476-4598-2-4","volume":"2","author":"F Wang","year":"2003","unstructured":"Wang F, Herrington M, Larsson J, Permert J: The relationship between diabetes and pancreatic cancer. Mol Cancer. 2003, 2: 4-10.1186\/1476-4598-2-4.","journal-title":"Mol Cancer"},{"key":"1092_CR18","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1158\/1055-9965.EPI-06-0188","volume":"15","author":"F Wang","year":"2006","unstructured":"Wang F, Gupta S, Holly EA: Diabetes mellitus and pancreatic cancer in a population-based case-control study in the San Francisco Bay Area, California. Cancer Epidemiol Biomarkers Prev. 2006, 15: 1458-1463. 10.1158\/1055-9965.EPI-06-0188.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"1092_CR19","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.pan.2012.02.003","volume":"12","author":"G Aggarwal","year":"2012","unstructured":"Aggarwal G, Rabe KG, Petersen GM, Chari ST: New-onset diabetes in pancreatic cancer: a study in the primary care setting. Pancreatology. 2012, 12: 156-161.","journal-title":"Pancreatology"},{"key":"1092_CR20","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S0002-9610(05)80405-2","volume":"165","author":"J Permert","year":"1993","unstructured":"Permert J, Adrian TE, Jacobsson P, Jorfelt L, Fruin AB, Larsson J: Is profound peripheral insulin resistance in patients with PaC caused by a tumor-associated factor?. Am J Surg. 1993, 165: 61-67. 10.1016\/S0002-9610(05)80405-2.","journal-title":"Am J Surg"},{"key":"1092_CR21","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1111\/j.1751-2980.2008.00359.x","volume":"10","author":"TT Kuang","year":"2009","unstructured":"Kuang TT, da Jin Y, Wang DS, Xu XF, Ni XL, Wu WC, Lou WH: Clinical epidemiological analysis of the relationship between pancreatic cancer and diabetes mellitus: data from a single institution in China. J Dig Dis. 2009, 10: 26-29. 10.1111\/j.1751-2980.2008.00359.x.","journal-title":"J Dig Dis"},{"key":"1092_CR22","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1097\/MPA.0b013e3182156e1b","volume":"40","author":"H Matsubayashi","year":"2011","unstructured":"Matsubayashi H, Maeda A, Kanemoto H, Uesaka K, Yamazaki K, Hironaka S, Miyagi Y, Ikehara H, Ono H, Klein A, Goggins M: Risk factors of familial pancreatic cancer in Japan: current smoking and recent onset of diabetes. Pancreas. 2011, 40: 974-978. 10.1097\/MPA.0b013e3182156e1b.","journal-title":"Pancreas"},{"key":"1092_CR23","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1002\/ijc.20210","volume":"110","author":"DK Bartsch","year":"2004","unstructured":"Bartsch DK, Kress R, Sina-Frey M, Grutzmann R, Gerdes B, Pilarsky C, Heise JW, Schulte KM, Colombo-Benkmann M, Schleicher C, Witzigmann H, Pridohl O, Ghadimi M, Horstmann OV, Berndorff W, Jochimsen L, Schmidt J, Eisold S, Estevez-Schwarz L, Hahn SA, Schulmann K, Bock W, Gress T, Zugel N, Breitschaft K, Prenzel K, Messmann H, Endlicher E, Schneider M, Ziegler A: Prevalence of familial pancreatic cancer in Germany. Int J Cancer. 2004, 110: 902-906. 10.1002\/ijc.20210.","journal-title":"Int J Cancer"},{"key":"1092_CR24","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1016\/S0016-5085(03)00272-5","volume":"124","author":"SJ Rulyak","year":"2003","unstructured":"Rulyak SJ, Lowenfels AB, Maisonneuve P, Brentnall TA: Risk factors for the development of pancreatic cancer in familial pancreatic cancer kindreds. Gastroenterology. 2003, 124: 1292-1299. 10.1016\/S0016-5085(03)00272-5.","journal-title":"Gastroenterology"},{"key":"1092_CR25","first-page":"S","volume":"138","author":"W Uni","year":"2010","unstructured":"Uni W, Shelly N, Richard Z: Pancreatic adenocarcinoma (PA) and diabetes mellitus (DM). Gastroenterology. 2010, 138: S-553.","journal-title":"Gastroenterology"},{"key":"1092_CR26","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s00125-009-1556-8","volume":"53","author":"AE Butler","year":"2010","unstructured":"Butler AE, Galasso R, Matveyenko A, Rizza RA, Dry S, Butler PC: Pancreatic duct replication is increased with obesity and type 2 diabetes in humans. Diabetologia. 2010, 53: 21-26. 10.1007\/s00125-009-1556-8.","journal-title":"Diabetologia"},{"key":"1092_CR27","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1053\/gast.2001.23258","volume":"120","author":"MB Schneider","year":"2001","unstructured":"Schneider MB, Matsuzaki H, Haorah J, Ulrich A, Standop J, Ding XZ, Adrian TE, Pour PM: Prevention of PaC induction in hamsters by metformin. Gastroenterology. 2001, 120: 1263-1270. 10.1053\/gast.2001.23258.","journal-title":"Gastroenterology"},{"key":"1092_CR28","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1210\/jc.85.3.1232","volume":"85","author":"J Liu","year":"2000","unstructured":"Liu J, Knezetic JA, Str\u00c3\u00b6mmer L, Permert J, Larsson J, Adrian TE: The intracellular mechanism of insulin resistance in pancreatic cancer patients. J Clin End Met. 2000, 85: 1232-1238. 10.1210\/jc.85.3.1232.","journal-title":"J Clin End Met"},{"key":"1092_CR29","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1002\/1520-6866(2001)21:1<59::AID-TCM6>3.0.CO;2-V","volume":"21","author":"J Permert","year":"2001","unstructured":"Permert J, Herrington M, Kazakoff K, Pour PM, Adrian TE: Early changes in islet hormone secretion in the hamster pancreatic cancer model. Teratog Carcinog Mutagen. 2001, 21: 59-67. 10.1002\/1520-6866(2001)21:1<59::AID-TCM6>3.0.CO;2-V.","journal-title":"Teratog Carcinog Mutagen"},{"key":"1092_CR30","doi-asserted-by":"publisher","first-page":"26","DOI":"10.4149\/neo_2009_01_26","volume":"56","author":"T Krechler","year":"2009","unstructured":"Krechler T, Jachymova M, Pavlikova M, Vecka M, Zeman M, Krska Z, Svestka T, Zak A: Polymorphism -23HPhI in the promoter of insulin gene and pancreatic cancer: a pilot study. Neoplasma. 2009, 56: 26-32. 10.4149\/neo_2009_01_26.","journal-title":"Neoplasma"},{"key":"1092_CR31","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1159\/000050095","volume":"18","author":"D Pantalone","year":"2001","unstructured":"Pantalone D, Ragionieri I, Nesi G: Improved survival in small pancreatic cancer. Dig Surg. 2001, 18: 41-46. 10.1159\/000050095.","journal-title":"Dig Surg"},{"key":"1092_CR32","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1245\/s10434-009-0789-6","volume":"17","author":"CK Chu","year":"2010","unstructured":"Chu CK, Mazo AE, Goodman M, Egnatashvili V, Sarmiento JM, Staley CA, Galloway JR, Adsay NV, Jacobs S, Kooby DA: Preoperative diabetes mellitus and long-term survival after resection of pancreatic adenocarcinoma. Ann Surg Oncol. 2010, 17: 502-513. 10.1245\/s10434-009-0789-6.","journal-title":"Ann Surg Oncol"},{"key":"1092_CR33","first-page":"431","volume":"104","author":"WE Fisher","year":"1988","unstructured":"Fisher WE, McCullough PJ, Ray MB, Rogers DH, Bell RH: Diabetes enhances growth of pancreatic carcinoma cells. Surgery. 1988, 104: 431-436.","journal-title":"Surgery"},{"key":"1092_CR34","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1158\/1940-6207.CAPR-10-0247","volume":"4","author":"X Dong","year":"2011","unstructured":"Dong X, Li Y, Chang P, Tang H, Hess KR, Abbruzzese JL, Li D: Glucose metabolism gene variants modulate the risk of pancreatic cancer. Cancer Prev Res (Phila). 2011, 4: 758-766. 10.1158\/1940-6207.CAPR-10-0247.","journal-title":"Cancer Prev Res (Phila)"},{"key":"1092_CR35","first-page":"139","volume":"37","author":"JP Fryzek","year":"2006","unstructured":"Fryzek JP, Garabrant DH, Schenk M, Kinnard M, Greenson JK, Sarkar FH: The association between selected risk factors for pancreatic cancer and the expression of p53 and K-ras codon 12 mutations. Int J Gastrointest Cancer. 2006, 37: 139-145.","journal-title":"Int J Gastrointest Cancer"},{"key":"1092_CR36","first-page":"2007","volume":"55","author":"U Bergmann","year":"1995","unstructured":"Bergmann U, Funatomi H, Yokoyama M, Beger HG, Korc M: Insulin-like growth factor I overexpression in human pancreatic cancer: evidence for autocrine and paracrine roles. Cancer Res. 1995, 55: 2007-2011.","journal-title":"Cancer Res"},{"key":"1092_CR37","doi-asserted-by":"publisher","first-page":"3467","DOI":"10.1158\/1055-9965.EPI-08-0514","volume":"17","author":"H Suzuki","year":"2008","unstructured":"Suzuki H, Li Y, Dong X, Hassan MM, Abbruzzese JL, Li D: Effect of insulin-like growth factor gene polymorphisms alone or in interaction with diabetes on the risk of pancreatic cancer. Cancer Epidemiol Biomarkers Prev. 2008, 17: 3467-3473. 10.1158\/1055-9965.EPI-08-0514.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"1092_CR38","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1053\/j.gastro.2010.04.042","volume":"139","author":"X Dong","year":"2010","unstructured":"Dong X, Javle M, Hess KR, Shroff R, Abbruzzese JL, Li D: Insulin-like growth factor axis gene polymorphisms and clinical outcomes in pancreatic cancer. Gastroenterology. 2010, 139: 464-473. 10.1053\/j.gastro.2010.04.042. 473.e1-3","journal-title":"Gastroenterology"},{"key":"1092_CR39","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.cca.2006.03.027","volume":"372","author":"D Basso","year":"2006","unstructured":"Basso D, Greco E, Fogar P, Pucci P, Flagiello A, Baldo G, Giunco S, Valerio A, Navaglia F, Zambon CF, Falda A, Pedrazzoli S, Plebani M: Pancreatic cancer-derived S-100A8 N-terminal peptide: a diabetes cause?. Clin Chim Acta. 2006, 372: 120-128. 10.1016\/j.cca.2006.03.027.","journal-title":"Clin Chim Acta"},{"key":"1092_CR40","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1002\/jcp.22355","volume":"226","author":"D Basso","year":"2011","unstructured":"Basso D, Greco E, Padoan A, Fogar P, Scorzeto M, Fadi E, Bozzato D, Moz S, Navaglia F, Zambon CF, Seraglia R, De Carlo E, Valerio A, Reggiani C, Pedrazzoli S, Plebani M: Altered intracellular calcium fluxes in pancreatic cancer induced diabetes mellitus: relevance of the S100A8 N-terminal peptide (NT-S100A8). J Cell Physiol. 2011, 226: 456-468. 10.1002\/jcp.22355.","journal-title":"J Cell Physiol"},{"key":"1092_CR41","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1002\/ijc.25188","volume":"127","author":"L Zhou","year":"2010","unstructured":"Zhou L, Zhang R, Wang L, Shen S, Okamoto H, Sugawara A, Xia L, Wang X, Noguchi N, Yoshikawa T, Uruno A, Yao W, Yuan Y: Upregulation of REG Ialpha accelerates tumor progression in pancreatic cancer with diabetes. Int J Cancer. 2010, 127: 1795-1803. 10.1002\/ijc.25188.","journal-title":"Int J Cancer"},{"key":"1092_CR42","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1080\/00365520601058452","volume":"42","author":"B Tingstedt","year":"2007","unstructured":"Tingstedt B, Johansson P, Andersson B, Andersson R: Predictive factors in pancreatic ductal adenocarcinoma: role of the inflammatory response. Scand J Gastroenterol. 2007, 42: 754-759. 10.1080\/00365520601058452.","journal-title":"Scand J Gastroenterol"},{"key":"1092_CR43","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S0009-8981(98)00125-9","volume":"277","author":"P Fogar","year":"1998","unstructured":"Fogar P, Basso D, Pasquali C, Piva MG, Brigato L, De Paoli M, Galeotti F, Corsini A, Plebani M: Portal but not peripheral serum levels of interleukin 6 could interfere with glucose metabolism in patients with pancreatic cancer. Clin Chim Acta. 1998, 277: 181-189. 10.1016\/S0009-8981(98)00125-9.","journal-title":"Clin Chim Acta"},{"key":"1092_CR44","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1136\/gut.2003.024471","volume":"53","author":"D Basso","year":"2004","unstructured":"Basso D, Millino C, Greco E, Romualdi C, Fogar P, Valerio A, Bellin M, Zambon CF, Navaglia F, Dussini N, Avogaro A, Pedrazzoli S, Lanfranchi G, Plebani M: Altered glucose metabolism and proteolysis in pancreatic cancer cell conditioned myoblasts: searching for a gene expression pattern with a microarray analysis of 5000 skeletal muscle genes. Gut. 2004, 53: 1159-1166. 10.1136\/gut.2003.024471.","journal-title":"Gut"},{"key":"1092_CR45","first-page":"1577","volume":"48","author":"M Takada","year":"2001","unstructured":"Takada M, Koizumi T, Toyama H, Suzuki Y, Kuroda Y: Differential expression of RAGE in human pancreatic carcinoma cells. Hepatogastroenterology. 2001, 48: 1577-1578.","journal-title":"Hepatogastroenterology"},{"key":"1092_CR46","first-page":"928","volume":"51","author":"M Takada","year":"2004","unstructured":"Takada M, Hirata K, Ajiki T, Suzuki Y, Kuroda Y: Expression of receptor for advanced glycation end products (RAGE) and MMP-9 in human pancreatic cancer cells. Hepatogastroenterology. 2004, 51: 928-930.","journal-title":"Hepatogastroenterology"},{"key":"1092_CR47","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1038\/414813a","volume":"414","author":"M Brownlee","year":"2001","unstructured":"Brownlee M: Biochemistry and molecular cell biology of diabetic complications. Nature. 2001, 414: 813-820. 10.1038\/414813a.","journal-title":"Nature"},{"key":"1092_CR48","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1172\/JCI119693","volume":"100","author":"JV Busik","year":"1997","unstructured":"Busik JV, Hootman SR, Greenidge CA, Henry DN: Glucosespecific regulation of aldose reductase in capan-1 human pancreatic duct cells in vitro. J Clin Invest. 1997, 100: 1685-1692. 10.1172\/JCI119693.","journal-title":"J Clin Invest"},{"key":"1092_CR49","first-page":"1279","volume":"25","author":"W Li","year":"2011","unstructured":"Li W, Ma Q, Li J, Guo K, Liu H, Han L, Ma G: Hyperglycemia enhances the invasive and migratory activity of pancreatic cancer cells via hydrogen peroxide. Oncol Rep. 2011, 25: 1279-1287.","journal-title":"Oncol Rep"},{"key":"1092_CR50","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1081\/CEH-120027330","volume":"26","author":"RK Sindhu","year":"2004","unstructured":"Sindhu RK, Koo JR, Roberts CK, Vaziri ND: Dysregulation of hepatic superoxide dismutase, catalase and glutathione peroxidase in diabetes: response to insulin and antioxidant therapies. Clin Exp Hypert. 2004, 26: 43-53. 10.1081\/CEH-120027330.","journal-title":"Clin Exp Hypert"},{"key":"1092_CR51","first-page":"1297","volume":"63","author":"JJ Cullen","year":"2003","unstructured":"Cullen JJ, Weydert C, Hinkhouse MM, Ritchie J, Domann FE, Spitz D, Oberley LW: The role of manganese superoxide dismutase in the growth of pancreatic adenocarcinoma. Cancer Res. 2003, 63: 1297-1303.","journal-title":"Cancer Res"},{"key":"1092_CR52","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1097\/00006676-200301000-00005","volume":"26","author":"JJ Cullen","year":"2003","unstructured":"Cullen JJ, Mitros FA, Oberley LW: Expression of antioxidant enzymes in diseases of the human pancreas: another link between chronic pancreatitis and pancreatic cancer. Pancreas. 2003, 26: 23-27. 10.1097\/00006676-200301000-00005.","journal-title":"Pancreas"},{"key":"1092_CR53","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1002\/(SICI)1522-2683(20000101)21:2<285::AID-ELPS285>3.0.CO;2-5","volume":"21","author":"K Suzuki","year":"2000","unstructured":"Suzuki K, Islam KN, Kaneto H, Ookawara T, Taniguchi N: The contribution of fructose and nitric oxide to oxidative stress in hamster islet tumor (HIT) cells through the inactivation of glutathione peroxidase. Electrophoresis. 2000, 21: 285-288. 10.1002\/(SICI)1522-2683(20000101)21:2<285::AID-ELPS285>3.0.CO;2-5.","journal-title":"Electrophoresis"},{"key":"1092_CR54","doi-asserted-by":"publisher","first-page":"5291","DOI":"10.1158\/0008-5472.CAN-04-1112","volume":"64","author":"C Veit","year":"2004","unstructured":"Veit C, Genze F, Menke A, Hoeffert S, Gress TM, Gierschik P, Giehl K: Activation of phosphatidylinositol 3-kinase and extracellular signal-regulated kinase is required for glial cell line-derived neurotrophic factor-induced migration and invasion of pancreatic carcinoma cells. Cancer Res. 2004, 64: 5291-5300. 10.1158\/0008-5472.CAN-04-1112.","journal-title":"Cancer Res"},{"key":"1092_CR55","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/S1359-6101(01)00012-0","volume":"12","author":"M Takahashi","year":"2001","unstructured":"Takahashi M: The GDNF\/RET signaling pathway and human diseases. Cytokine Growth Factor Rev. 2001, 12: 361-373. 10.1016\/S1359-6101(01)00012-0.","journal-title":"Cytokine Growth Factor Rev"},{"key":"1092_CR56","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s11010-010-0617-0","volume":"347","author":"H Liu","year":"2011","unstructured":"Liu H, Ma QY, Li JH: High glucose promotes cell proliferation and enhances GDNF and RET expression in pancreatic cancer cells. Mol Cell Biochem. 2011, 347: 95-101. 10.1007\/s11010-010-0617-0.","journal-title":"Mol Cell Biochem"},{"key":"1092_CR57","doi-asserted-by":"publisher","first-page":"e27074","DOI":"10.1371\/journal.pone.0027074","volume":"6","author":"L Han","year":"2011","unstructured":"Han L, Ma Q, Li J, Liu H, Li W, Ma G, Xu Q, Zhou S, Wu E: High glucose promotes pancreatic cancer cell proliferation via the induction of EGF expression and transactivation of EGFR. PLoS One. 2011, 6: e27074-10.1371\/journal.pone.0027074.","journal-title":"PLoS One"},{"key":"1092_CR58","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.mehy.2008.05.001","volume":"71","author":"JH Li","year":"2008","unstructured":"Li JH, Ma QY: Hyperglycemia promotes the perineural invasion in pancreatic cancer. Med Hypotheses. 2008, 71: 386-389. 10.1016\/j.mehy.2008.05.001.","journal-title":"Med Hypotheses"},{"key":"1092_CR59","doi-asserted-by":"publisher","first-page":"e17385","DOI":"10.1371\/journal.pone.0017385","volume":"6","author":"J Li","year":"2011","unstructured":"Li J, Ma Q, Liu H, Guo K, Li F, Li W, Han L, Wang F, Wu E: Relationship between neural alteration and perineural invasion in pancreatic cancer patients with hyperglycemia. PLoS One. 2011, 6: e17385-10.1371\/journal.pone.0017385.","journal-title":"PLoS One"},{"key":"1092_CR60","doi-asserted-by":"publisher","first-page":"2318","DOI":"10.1038\/ajg.2009.253","volume":"104","author":"R Pannala","year":"2009","unstructured":"Pannala R, Leibson CL, Rabe KG, Timmons LJ, Ransom J, de Andrade M, Petersen GM, Chari ST: Temporal association of changes in fasting blood glucose and body mass index with diagnosis of pancreatic cancer. Am J Gastroenterol. 2009, 104: 2318-2325. 10.1038\/ajg.2009.253.","journal-title":"Am J Gastroenterol"},{"key":"1092_CR61","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1053\/j.gastro.2007.10.040","volume":"134","author":"ST Chari","year":"2008","unstructured":"Chari ST, Leibson CL, Rabe KG, Timmons LJ, Ransom J, de Andrade M, Petersen GM: Pancreatic cancer-associated diabetes mellitus: prevalence and temporal association with diagnosis of cancer. Gastroenterology. 2008, 134: 95-101. 10.1053\/j.gastro.2007.10.040.","journal-title":"Gastroenterology"},{"key":"1092_CR62","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/S1470-2045(08)70337-1","volume":"10","author":"R Pannala","year":"2009","unstructured":"Pannala R, Basu A, Petersen GM, Chari ST: New-onset diabetes: a potential clue to the early diagnosis of pancreatic cancer. Lancet Oncol. 2009, 10: 88-95. 10.1016\/S1470-2045(08)70337-1.","journal-title":"Lancet Oncol"},{"key":"1092_CR63","volume-title":"National Diabetes Fact Sheet","author":"Centers for Disease Control and Prevention","year":"2007","unstructured":"Centers for Disease Control and Prevention: National Diabetes Fact Sheet. 2007"},{"key":"1092_CR64","first-page":"1391","volume":"138","author":"HY Park","year":"2010","unstructured":"Park HY, Song SY, Cho HC, Lee KH, Lee KT, Lee JK: Clinical characteristics of pancreatic cancer-associated new onset diabetes. Gastroenterology. 2010, 138: 1391-","journal-title":"Gastroenterology"},{"key":"1092_CR65","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1056\/NEJM199407143310203","volume":"331","author":"L Gullo","year":"1994","unstructured":"Gullo L, Pezzilli R, Morselli-Labate AM, Italian Pancreatic Cancer Study Group: Diabetes and the risk of pancreatic cancer. N Engl J Med. 1994, 331: 81-84. 10.1056\/NEJM199407143310203.","journal-title":"N Engl J Med"},{"key":"1092_CR66","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1097\/MPA.0b013e318220816a","volume":"40","author":"PA Hart","year":"2011","unstructured":"Hart PA, Kamada P, Rabe KG, Srinivasan S, Basu A, Aggarwal G, Chari ST: Weight loss precedes cancer-specific symptoms in pancreatic cancer-associated diabetes mellitus. Pancreas. 2011, 40: 768-772. 10.1097\/MPA.0b013e318220816a.","journal-title":"Pancreas"},{"key":"1092_CR67","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.2337\/dc10-2006","volume":"34","author":"HF Chen","year":"2011","unstructured":"Chen HF, Chen P, Li CY: Risk of malignant neoplasm of the pancreas in relation to diabetes: a population-based study in Taiwan. Diabetes Care. 2011, 34: 1177-1179. 10.2337\/dc10-2006.","journal-title":"Diabetes Care"},{"key":"1092_CR68","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1053\/j.gastro.2008.01.039","volume":"134","author":"R Pannala","year":"2008","unstructured":"Pannala R, Leirness JB, Bamlet WR, Basu A, Petersen GM, Chari ST: Prevalence and clinical profile of pancreatic cancer-associated diabetes mellitus. Gastroenterology. 2008, 134: 981-987. 10.1053\/j.gastro.2008.01.039.","journal-title":"Gastroenterology"},{"key":"1092_CR69","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s11606-009-1237-9","volume":"25","author":"MV Lin","year":"2010","unstructured":"Lin MV, Bishop G, Benito-Herrero M: Diabetic ketoacidosis in type 2 diabetics: a novel presentation of pancreatic adenocarcinoma. J Gen Intern Med. 2010, 25: 369-373. 10.1007\/s11606-009-1237-9.","journal-title":"J Gen Intern Med"},{"key":"1092_CR70","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1002\/bjs.1800800841","volume":"80","author":"J Permert","year":"1993","unstructured":"Permert J, Ihse I, Jorfeldt L, von Schenck H, Arnquist HJ, Larsson J: Improved glucose metabolism after subtotal pancreatectomy for pancreatic cancer. Br J Surg. 1993, 80: 1047-1050. 10.1002\/bjs.1800800841.","journal-title":"Br J Surg"},{"key":"1092_CR71","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1159\/000085276","volume":"5","author":"ST Chari","year":"2005","unstructured":"Chari ST, Zapiach M, Yadav D, Rizza RA: Beta-cell function and insulin resistance evaluated by HOMA in pancreatic cancer subjects with varying degrees of glucose intolerance. Pancreatology. 2005, 5: 229-233. 10.1159\/000085276.","journal-title":"Pancreatology"},{"key":"1092_CR72","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1038\/335632a0","volume":"335","author":"B Leighton","year":"1988","unstructured":"Leighton B, Cooper GJ: Pancreatic amylin and calcitonin gene-related peptide cause resistance to insulin in skeletal muscle in vitro. Nature. 1988, 335: 632-635. 10.1038\/335632a0.","journal-title":"Nature"},{"key":"1092_CR73","first-page":"423","volume":"25","author":"M Saruc","year":"2010","unstructured":"Saruc M, Iki K, Pour PM: Morphometric studies in human pancreatic cancer argues against the etiological role of type 2 diabetes in pancreatic cancer. Histol Histopathol. 2010, 25: 423-432.","journal-title":"Histol Histopathol"},{"key":"1092_CR74","doi-asserted-by":"publisher","first-page":"S71","DOI":"10.1016\/j.amjsurg.2007.05.024","volume":"194","author":"I Katsumichi","year":"2007","unstructured":"Katsumichi I, Pour PM: Diabetes mellitus in pancreatic cancer: is it a causal relationship?. Am J Surg. 2007, 194: S71-S75. 10.1016\/j.amjsurg.2007.05.024.","journal-title":"Am J Surg"},{"key":"1092_CR75","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.4161\/cbt.8.16.9006","volume":"8","author":"A Kolb","year":"2009","unstructured":"Kolb A, Rieder S, Born D, Giese NA, Giese T, Rudofsky G, Werner J, B\u00c3\u00bcchler MW, Friess H, Esposito I, Kleeff J: Glucagon\/insulin ratio as a potential biomarker for pancreatic cancer in patients with new-onset diabetes mellitus. Cancer Biol Ther. 2009, 8: 1527-1533.","journal-title":"Cancer Biol Ther"},{"key":"1092_CR76","first-page":"S-551","volume":"138","author":"G Aggarwal","year":"2010","unstructured":"Aggarwal G, Klee G, Fernandez-Zapico ME, Klee EW, Smyrk TC, Andrade M, Petersen GM, Chari ST: Adrenomedullin: a biomarker of pancreatic cancer-associated diabetes?. Gastroenterology. 2010, 138: S-551-","journal-title":"Gastroenterology"},{"key":"1092_CR77","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1471-230X-11-5","volume":"11","author":"RN Sharaf","year":"2011","unstructured":"Sharaf RN, Butte AJ, Montgomery KD, Pai R, Dudley JT, Pasricha PJ: Computational prediction and experimental validation associating FABP-1 and pancreatic adenocarcinoma with diabetes. BMC Gastroenterol. 2011, 11: 5-10.1186\/1471-230X-11-5.","journal-title":"BMC Gastroenterol"},{"key":"1092_CR78","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1038\/ajg.2010.32","volume":"105","author":"H Huang","year":"2010","unstructured":"Huang H, Dong X, Kang MX, Xu B, Chen Y, Zhang B, Chen J, Xie QP, Wu YL: Novel blood biomarkers of pancreatic cancer-associated diabetes mellitus identified by peripheral blood-based gene expression profiles. Am J Gastroenterol. 2010, 105: 1661-1669. 10.1038\/ajg.2010.32.","journal-title":"Am J Gastroenterol"},{"key":"1092_CR79","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/S0016-5085(98)70641-9","volume":"114","author":"X Ding","year":"1998","unstructured":"Ding X, Flatt PR, Permert J, Adrian TE: Pancreatic cancer cells selectively stimulate islet beta cells to secrete amylin. Gastroenterology. 1998, 114: 130-138. 10.1016\/S0016-5085(98)70641-9.","journal-title":"Gastroenterology"},{"key":"1092_CR80","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1007\/s00432-010-0820-0","volume":"136","author":"Q Guo","year":"2010","unstructured":"Guo Q, Kang M, Zhang B, Chen Y, Dong X, Wu Y: Elevated levels of CA 19-9 and CEA in pancreatic cancer-associated diabetes. J Cancer Res Clin Oncol. 2010, 136: 1627-1631. 10.1007\/s00432-010-0820-0.","journal-title":"J Cancer Res Clin Oncol"},{"key":"1092_CR81","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1007\/s11745-011-3588-3","volume":"46","author":"P Sookwong","year":"2011","unstructured":"Sookwong P, Nakagawa K, Fujita I, Shoji N, Miyazawa T: Amadori-glycated phosphatidylethanolamine, a potential marker for hyperglycemia, in streptozotocin-induced diabetic rats. Lipids. 2011, 46: 943-952. 10.1007\/s11745-011-3588-3.","journal-title":"Lipids"},{"key":"1092_CR82","doi-asserted-by":"publisher","first-page":"2542","DOI":"10.1016\/j.febslet.2012.06.027","volume":"586","author":"T Eitsuka","year":"2012","unstructured":"Eitsuka T, Nakagawa K, Ono Y, Tatewaki N, Nishida H, Kurata T, Shoji N, Miyazawa T: Amadori-glycated phosphatidylethanolamine up-regulates telomerase activity in PANC-1 human pancreatic carcinoma cells. FEBS Lett. 2012, 586: 2542-2547. 10.1016\/j.febslet.2012.06.027.","journal-title":"FEBS Lett"},{"key":"1092_CR83","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1515\/CCLM.2009.158","volume":"47","author":"F Navaglia","year":"2009","unstructured":"Navaglia F, Fogar P, Basso D, Greco E, Padoan A, Tonidandel L, Fadi E, Zambon CF, Bozzato D, Moz S, Seraglia R, Pedrazzoli S, Plebani M: Pancreatic cancer biomarkers discovery by surface-enhanced laser desorption and ionization time-of-flight mass spectrometry. Clin Chem Lab Med. 2009, 47: 713-723.","journal-title":"Clin Chem Lab Med"},{"key":"1092_CR84","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/j.bbrc.2009.10.019","volume":"390","author":"K Fukamachi","year":"2009","unstructured":"Fukamachi K, Tanaka H, Hagiwara Y, Ohara H, Joh T, Iigo M, Alexander DB, Xu J, Long N, Takigahira M, Yanagihara K, Hino O, Saito I, Tsuda H: An animal model of preclinical diagnosis of pancreatic ductal adenocarcinomas. Biochem Biophys Res Commun. 2009, 390: 636-641. 10.1016\/j.bbrc.2009.10.019.","journal-title":"Biochem Biophys Res Commun"},{"key":"1092_CR85","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.1111\/j.1572-0241.2007.01480.x","volume":"102","author":"M Pelaez-Luna","year":"2007","unstructured":"Pelaez-Luna M, Takahashi N, Fletcher JG, Chari ST: Resectability of presymptomatic pancreatic cancer and its relationship to onset of diabetes: a retrospective review of CT scans and fasting glucose values prior to diagnosis. Am J Gastroenterol. 2007, 102: 2157-2163. 10.1111\/j.1572-0241.2007.01480.x.","journal-title":"Am J Gastroenterol"},{"key":"1092_CR86","doi-asserted-by":"publisher","first-page":"e21368","DOI":"10.1371\/journal.pone.0021368","volume":"6","author":"CH Chang","year":"2011","unstructured":"Chang CH, Toh S, Lin JW, Chen ST, Kuo CW, Chuang LM, Lai MS: Associated with insulin glargine among adult type 2 diabetes patients - a nationwide cohort study. PLoS One. 2011, 6: e21368-10.1371\/journal.pone.0021368.","journal-title":"PLoS One"},{"key":"1092_CR87","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1111\/j.1582-4934.2010.01083.x","volume":"15","author":"YH Feng","year":"2011","unstructured":"Feng YH, Velazquez-Torres G, Gully C, Chen J, Lee MH, Yeung SC: The impact of type 2 diabetes and antidiabetic drugs on cancer cell growth. J Cell Mol Med. 2011, 15: 825-836. 10.1111\/j.1582-4934.2010.01083.x.","journal-title":"J Cell Mol Med"},{"key":"1092_CR88","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1007\/s11605-011-1448-3","volume":"15","author":"RB Chagpar","year":"2011","unstructured":"Chagpar RB, Martin RC, Ahmad SA, Kim HJ, Rupp C, Weber S, Ebelhar A, Gilbert J, Brinkman A, Winslow E, Cho CS, Kooby D, Chu CK, Staley CA, McMasters KM, Scoggins CR: Medically managed hypercholesterolemia and insulin-dependent diabetes mellitus preoperatively predicts poor survival after surgery for pancreatic cancer. J Gastrointest Surg. 2011, 15: 551-557. 10.1007\/s11605-011-1448-3.","journal-title":"J Gastrointest Surg"},{"key":"1092_CR89","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1471-2407-11-20","volume":"11","author":"MS Lee","year":"2011","unstructured":"Lee MS, Hsu CC, Wahlqvist ML, Tsai HN, Chang YH, Huang YC: Type 2 diabetes increases and metformin reduces total, colorectal, liver and pancreatic cancer incidences in Taiwanese: a representative population prospective cohort study of 800,000 individuals. BMC Cancer. 2011, 11: 20-10.1186\/1471-2407-11-20.","journal-title":"BMC Cancer"},{"key":"1092_CR90","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1080\/13813450902878054","volume":"115","author":"S Becker","year":"2009","unstructured":"Becker S, Dossus L, Kaaks R: Obesity related hyperinsulinaemia and hyperglycaemia and cancer development. Arch Physiol Biochem. 2009, 115: 86-96. 10.1080\/13813450902878054.","journal-title":"Arch Physiol Biochem"},{"key":"1092_CR91","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1007\/s00125-009-1440-6","volume":"52","author":"CJ Currie","year":"2009","unstructured":"Currie CJ, Poole CD, Gale EA: The influence of glucose-lowering therapies on cancer risk in type 2 diabetes. Diabetologia. 2009, 52: 1766-1777. 10.1007\/s00125-009-1440-6.","journal-title":"Diabetologia"},{"key":"1092_CR92","doi-asserted-by":"publisher","first-page":"10269","DOI":"10.1158\/0008-5472.CAN-06-1500","volume":"66","author":"M Zakikhani","year":"2006","unstructured":"Zakikhani M, Dowling R, Fantus IG, Sonenberg N, Pollak M: Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells. Cancer Res. 2006, 66: 10269-10273. 10.1158\/0008-5472.CAN-06-1500.","journal-title":"Cancer Res"},{"key":"1092_CR93","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.1158\/1078-0432.CCR-09-2229","volume":"16","author":"E Rozengurt","year":"2010","unstructured":"Rozengurt E, Sinnett-Smith J, Kisfalvi K: Crosstalk between insulin\/insulin-like growth factor-1 receptors and G protein-coupled receptor signaling systems: a novel target for the antidiabetic drug metformin in pancreatic cancer. Clin Cancer Res. 2010, 16: 2505-2511. 10.1158\/1078-0432.CCR-09-2229.","journal-title":"Clin Cancer Res"},{"key":"1092_CR94","doi-asserted-by":"publisher","first-page":"6539","DOI":"10.1158\/0008-5472.CAN-09-0418","volume":"69","author":"K Kisfalvi","year":"2009","unstructured":"Kisfalvi K, Eibl G, Sinnett-Smith J, Rozengurt E: Metformin disrupts crosstalk between G protein-coupled receptor and insulin receptor signaling systems and inhibits pancreatic cancer growth. Cancer Res. 2009, 69: 6539-6545. 10.1158\/0008-5472.CAN-09-0418.","journal-title":"Cancer Res"},{"key":"1092_CR95","first-page":"2210","volume":"293","author":"SD Nath","year":"2005","unstructured":"Nath SD, Habib SL, Abboud HE: Fasting serum glucose level and cancer risk in Korean men and women. JAMA. 2005, 293: 2210-2211.","journal-title":"JAMA"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1477-7819-10-171.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T20:18:14Z","timestamp":1630527494000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/1477-7819-10-171"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,24]]},"references-count":95,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["1092"],"URL":"https:\/\/doi.org\/10.1186\/1477-7819-10-171","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8,24]]},"assertion":[{"value":"20 April 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2012","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2012","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"171"}}